(Q34743421)

4 August 2017

title

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels (English)

1 reference

4 August 2017

1 reference

1 reference

extrapyramidal symptoms

1 reference

4

Weinberger DR

1 reference

4 August 2017

Knable MB

1

1 reference

4 August 2017

Heinz A

series ordinal

2

1 reference

4 August 2017

Raedler T

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

4 August 2017

1 reference

4 August 2017

volume

75

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

91-101

1 reference

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

Dopamine receptor occupancy and plasma haloperidol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2897%2900023-1

7 January 2021

10.1016/S0925-4927(97)00023-1

Identifiers

DOI

1 reference

4 August 2017

1 reference